78 related articles for article (PubMed ID: 15531294)
1. Visualization of naturally occurring Foxp3+ regulatory T cells in normal and tumor-bearing mice.
Hontsu S; Yoneyama H; Ueha S; Terashima Y; Kitabatake M; Nakano A; Ito T; Kimura H; Matsushima K
Int Immunopharmacol; 2004 Dec; 4(14):1785-93. PubMed ID: 15531294
[TBL] [Abstract][Full Text] [Related]
2. Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling.
Ordoñez-Rueda D; Lozano F; Sarukhan A; Raman C; Garcia-Zepeda EA; Soldevila G
Eur J Immunol; 2009 Aug; 39(8):2233-47. PubMed ID: 19609976
[TBL] [Abstract][Full Text] [Related]
3. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Fontenot JD; Gavin MA; Rudensky AY
Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
[TBL] [Abstract][Full Text] [Related]
4. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
6. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
7. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
[TBL] [Abstract][Full Text] [Related]
8. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
9. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice.
Chiu BC; Stolberg VR; Zhang H; Chensue SW
Mech Ageing Dev; 2007; 128(11-12):618-27. PubMed ID: 17961632
[TBL] [Abstract][Full Text] [Related]
10. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
[TBL] [Abstract][Full Text] [Related]
11. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells.
Pacholczyk R; Ignatowicz H; Kraj P; Ignatowicz L
Immunity; 2006 Aug; 25(2):249-59. PubMed ID: 16879995
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
[TBL] [Abstract][Full Text] [Related]
13. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
[TBL] [Abstract][Full Text] [Related]
14. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.
Zelenay S; Lopes-Carvalho T; Caramalho I; Moraes-Fontes MF; Rebelo M; Demengeot J
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4091-6. PubMed ID: 15753306
[TBL] [Abstract][Full Text] [Related]
15. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice.
Polanczyk MJ; Hopke C; Huan J; Vandenbark AA; Offner H
J Neuroimmunol; 2005 Dec; 170(1-2):85-92. PubMed ID: 16253347
[TBL] [Abstract][Full Text] [Related]
16. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
17. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
[TBL] [Abstract][Full Text] [Related]
18. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.
Mor A; Keren G; Kloog Y; George J
Eur J Immunol; 2008 Jun; 38(6):1493-502. PubMed ID: 18461565
[TBL] [Abstract][Full Text] [Related]
19. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.
Nishikawa H; Kato T; Tawara I; Saito K; Ikeda H; Kuribayashi K; Allen PM; Schreiber RD; Sakaguchi S; Old LJ; Shiku H
J Exp Med; 2005 Mar; 201(5):681-6. PubMed ID: 15753203
[TBL] [Abstract][Full Text] [Related]
20. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.
Morgan ME; van Bilsen JH; Bakker AM; Heemskerk B; Schilham MW; Hartgers FC; Elferink BG; van der Zanden L; de Vries RR; Huizinga TW; Ottenhoff TH; Toes RE
Hum Immunol; 2005 Jan; 66(1):13-20. PubMed ID: 15620457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
